PRESS RELEASE

D360 Express Data Platform

Certara, the provider of decision support technology and consulting services for optimising drug development and improving health outcomes, has announced the availability of D360 Express.

The R&D informatics platform provides scientific data integration, analysis, and visualisation and is specifically packaged for discovery scientists at small biopharmaceutical companies.

['The feedback that we have received from the 6,500 scientists using D360 has been overwhelmingly positive with regard to the platform’s ability to reduce research cycle times, enabling them to make quicker, more effective decisions,' said Certara chief executive officer Edmundo Muniz.

'Those scientists estimate that by using D360 they have been able to increase by more than 50 percent the time they spend performing pivotal scientific modelling and analysis instead of provisioning data.'

D360 is described as a scientifically intelligent data access solution for small molecule discovery scientists. It combines data from multiple cheminformatics and bioinformatics databases, allowing users to query those sources in a common GUI. D360 also enables those scientists to visualise their query results and make informed go/no go and next-step decisions.

Company: 
Feature

Robert Roe looks at recent developments in processor and accelerator technology

Feature

Robert Roe discusses the potential for software-defined storage with Excelero’s Josh Goldenhar

Feature

With innovation in cooling technology increasingly more important to ensure energy, performance and cost efficiency of HPC, Keely Portway speaks to experts to find out what is driving the latest innovations

Feature

Robert Roe talks to Southampton University’s Oz Parchment about the decision-making behind the latest HPC system at the University

Feature

Gemma Church explains the background behind explosive growth in the simulation and modelling of low- and high-frequency electronics